Testosterone Therapy in the Male Cancer Patient

作者: Abraham Morgentaler

DOI: 10.1007/978-1-60761-916-1_47

关键词: Prostate cancerErectile dysfunctionCancerMedicineInternal medicineContraindicationLibidoAndrogenDepression (differential diagnoses)Testosterone (patch)

摘要: One of the more controversial issues over last several years has been use testosterone (T) therapy (TTh) in men with prostate cancer (PCa). Many 50 or older suffer from ­symptoms deficiency, including symptoms erectile dysfunction, diminished libido, fatigue, depression, and sense decreased vitality. TTh effectively treats these many men, may provide additional benefits such as increased strength, muscle mass, bone mineral density (Table 47.1). Yet there a long-standing widely held concern that higher serum T causes rapid PCa growth. For this reason, any history considered an absolute contraindication to TTh, even apparent cure.

参考文章(52)
L. K. Heilbrun, W. A. Sakr, D. J. Grignon, J. D. Crissman, J. J.E. Pontes, B. J. Cassin, G. P. Haas, High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. in Vivo. ,vol. 8, pp. 439- 444 ,(1994)
Abraham Morgentaler, Testosterone replacement therapy and prostate risks: where's the beef? Canadian Journal of Urology. pp. 40- 43 ,(2006)
John Bogdanos, Dimitrios Karamanolakis, Constantine Milathianakis, Peter Lembessis, Theocharis Lambou, Nicholas Pissimissis, Antonis Halapas, Nick Dessypris, Eleni T. H. Petridou, Antigone Sourla, Michael Koutsilieris, Serum Testosterone: A Potentially Adjunct Screening Test for the Assessment of the Risk of Prostate Cancer Among Men with Modestly Elevated PSA Values (≥3.0 and <10.0 ng/ml) Anticancer Research. ,vol. 26, pp. 3159- 3166 ,(2006)
Abraham Morgentaler, Carl O Bruning, William C DeWolf, Occult Prostate Cancer in Men With Low Serum Testosterone Levels JAMA: The Journal of the American Medical Association. ,vol. 276, pp. 1904- 1906 ,(1996) , 10.1001/JAMA.1996.03540230054035
Ernani Luis Rhoden, Charles Edison Riedner, Abraham Morgentaler, The Ratio of Serum Testosterone-to-Prostate Specific Antigen Predicts Prostate Cancer in Hypogonadal Men The Journal of Urology. ,vol. 179, pp. 1741- 1745 ,(2008) , 10.1016/J.JURO.2008.01.045
Mohit Khera, Ethan D. Grober, Bobby Najari, John S. Colen, Osama Mohamed, Dolores J. Lamb, Larry I. Lipshultz, Testosterone replacement therapy following radical prostatectomy. The Journal of Sexual Medicine. ,vol. 6, pp. 1165- 1170 ,(2009) , 10.1111/J.1743-6109.2009.01161.X